ω-3 oil intake during weight loss in obese women results in remodelling of plasma triglyceride and fatty acids

Metabolomics

Volumn 5, Issue 3, 2009, Pages 363-374

  McCombie, Gregor ^a   Browning, Lucy M ^b   Titman, Christopher M ^a   Song, Molly ^a   Shockcor, John ^c   Jebb, Susan A ^b   Griffin, Julian L ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b MRC HUMAN NUTRITION RESEARCH   (United Kingdom)

^c WATERS CORPORATION   (United States)

Author keywords

GC MS; LC MS; Metabolomics; Metabonomics weight loss; NMR; Omega 3 polyunsaturated fatty acids; PUFA; Triacylglycerol

Indexed keywords

EID: 70149111253     PISSN: 15733882     EISSN: 15733890     Source Type: Journal    
DOI: 10.1007/s11306-009-0161-7     Document Type: Article

References (24)

1. Bligh, E. G., & Dyer, W. J. (1959). A rapid method of total lipid extraction and purification. Canadian Journal of Biochemistry and Physiology, 37, 911-917.
2. Browning, L. M., et al. (2004). Elevated sialic acid, but not CRP, predicts features of the metabolic syndrome independently of BMI in women. International Journal of Obesity, 28, 1004-1010. doi: 10.1038/ sj.ijo.0802711.
3. Chan, J. M., et al. (1994). Obesity, fat distribution, and weight-gain as risk-factors for clinical diabetes in men. Diabetes Care, 17, 961-969. doi: 10.2337/diacare.17.9.961.
4. Colditz, G. A., et al. (1990). Weight as a risk factor for clinical diabetes in women. American Journal of Epidemiology, 132, 501-513.
5. Folch, J., Lees, M., & Sloane-Stanley, G. H. (1957). A simple method for the isolation and purification of total lipids from animal tissues. The Journal of Biological Chemistry, 226, 497-509.
6. Griffin, J. L. (2004). Metabolic profiles to define the genome: Can we hear the phenotypes? Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, 359, 857-871. doi: 10.1098/ rstb.2003.1411.
7. Harris, W. S. (1996). n-3 Fatty acids and lipoproteins: Comparison of results from human and animal studies. Lipids, 31, 243-252. doi: 10.1007/ BF02529870.
8. Hill, A. M., et al. (2007). Combining fish-oil supplements with regular aerobic exercise improves body composition and cardiovascular disease risk factors. The American Journal of Clinical Nutrition, 85, 1267-1274.
9. Innis, S. M. (2003). Perinatal biochemistry and physiology of long-chain polyunsaturated fatty acids. The Journal of Pediatrics, 143, S1-S8. doi: 10.1067/S0022-3476(03)00396-2.
10. Innis, S. M., Vaghri, Z., & King, D. J. (2004). N-6 Docosapentaenoic acid is not a predictor of low docosahexaenoic acid status in Canadian preschool children. The American Journal of Clinical Nutrition, 80, 768-773.
11. James, M. J., Gibson, R. A., & Cleland, L. G. (2000). Dietary polyunsaturated fatty acids and inflammatory mediator production. The American Journal of Clinical Nutrition, 71, 343S-348S.
12. Knowler, W. C., et al. (2002). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. The New England Journal of Medicine, 346, 393-403. doi: 10.1056/NEJMoa012512.
13. Krebs, J. D., et al. (2006). Additive benefits of long-chain n-3 polyunsaturated fatty acids and weight-loss in the management of cardiovascular disease risk in overweight hyperinsulinaemic women. International Journal of Obesity, 30, 1535-1544. doi: 10.1038/ sj.ijo.0803309.
14. Kriketos, A. D., et al. (2001). Role of weight loss and polyunsaturated fatty acids in improving metabolic fitness in moderately obese, moderately hypertensive subjects. Journal of Hypertension, 19, 1745-1754. doi: 10.1097/00004872-200110000-00007.
15. Manson, J. A. E., et al. (1990). A prospective-study of obesity and risk of coronary heart-disease in women. The New England Journal of Medicine, 322, 882-889.
16. Manson, J. E., et al. (1995). Body-weight and mortality among women. The New England Journal of Medicine, 333, 677-685. doi: 10.1056/ NEJM199509143331101.
17. Medina-Gomez, G., et al. (2007). PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism. PLOS Genetics, 3(4), e64.
18. Morrison, W. R., & Smith, L. M. (1964). Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride - Methanol. Journal of Lipid Research, 5, 600-608.
19. Ogden, C. L., et al. (2006). Prevalence of overweight and obesity in the United States, 1999-2004. Journal of the American Medical Association, 295, 1549-1555. doi: 10.1001/jama.295.13.1549.
20. Schwab, U., et al. (2008). Triacylglycerol fatty acid composition in diet-induced weight loss in subjects with abnormal glucose metabolism - The GENOBIN study. PLoS ONE, 2, e2630. doi: 10.1371/journal.pone.0002630.
21. Stamler, R., et al. (1978). Weight and blood-pressure findings in hypertension screening of 1-million Americans. JAMA - Journal of the American Medical Association, 240, 1607-1610. doi: 10.1001/ jama.240.15.1607.
22. Tuomilehto, J., et al. (2001). Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. The New England Journal of Medicine, 344, 1343-1350. doi: 10.1056/ NEJM200105033441801.
23. Weckwerth, W. (2003). Metabolomics in systems biology. Annual Review of Plant Biology, 54, 669-689. doi: 10.1146/ annurev.arplant.54.031902.135014.
24. Yetukuri, L., et al. (2007). Bioinformatics strategies for lipidomics analysis: Characterization of obesity related hepatic steatosis. BMC Systems Biology, 15(1), 12.